Plain-English translation of NCT07604467 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at a condition called Takotsubo syndrome—a temporary heart weakness that often happens after emotional or physical stress. Researchers want to understand whether CD34+ stem cells (special cells in your blood that help maintain healthy blood vessels in the heart) play a role in how severe the heart weakness is and how well your heart recovers. By studying your blood samples and heart function over 6 months, scientists hope to find new ways to diagnose and treat this condition.
Takotsubo syndrome can cause serious, lasting heart problems in some patients, but doctors don't fully understand what causes it or why some people recover well while others don't. This medication or treatment approach is being explored because early research suggests that these stem cells may be key to how the heart's tiny blood vessels heal and function after stress.
You likely qualify if…
You likely don't qualify if…
You will visit the research center at the time of your Takotsubo diagnosis and again 6 months later. During each visit, doctors will take a blood sample to count your stem cells and perform heart imaging (like an echocardiogram) to measure how well your heart is working. The study is observational, meaning researchers are watching and measuring rather than giving you a new medication—they simply want to see if there's a connection between your stem cell levels and your heart's recovery.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Slovenia
Sponsor
University Medical Centre Ljubljana
Enrollment target
~40 participants
Started
September 2021
Primary completion
June 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mark Jovanović, MD
University Medical Centre Ljubljana
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.